Institute for Oncology and Radiology of Serbia ( Site 0780)

Belgrade, Beograd 11000

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Solid Tumors

Studies at this site

• A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080) — Completed